LGND vs GILD: Which Stock is Better?
Side-by-side comparison of Ligand Pharmaceuticals Inc and Gilead Sciences Inc in 2026
LGND
Ligand Pharmaceuticals Inc
$231.82
GILD
Gilead Sciences Inc
$137.64
Key Metrics Comparison
| Metric | LGND | GILD | Winner |
|---|---|---|---|
| Market Cap | $4.62B | $170.84B | GILD |
| P/E Ratio | 37.82 | 20.27 | GILD |
| EPS (TTM) | $6.13 | $6.79 | GILD |
| Revenue Growth | 0.4% | 0.0% | LGND |
| Gross Margin | 64.3% | 78.8% | GILD |
Analyze LGND
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is LGND or GILD a better investment?
Comparing LGND and GILD: Ligand Pharmaceuticals Inc has a market cap of $4.62B while Gilead Sciences Inc has $170.84B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between LGND and GILD?
LGND (Ligand Pharmaceuticals Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: LGND or GILD?
Based on P/E ratios, GILD trades at a lower multiple (20.3x vs 37.8x).
Which is growing faster: LGND or GILD?
LGND has higher revenue growth at 0.4% vs 0.0% for GILD.
Which company is more profitable: LGND or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 64.3% for LGND.
Which is the larger company: LGND or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $170.84B compared to $4.62B for LGND.
Should I buy LGND or GILD in 2026?
Both LGND and GILD have investment merit. LGND trades at $231.82 while GILD trades at $137.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between LGND and GILD stock?
Key differences: Market Cap ($4.62B vs $170.84B), P/E Ratio (37.8x vs 20.3x), Revenue Growth (0.4% vs 0.0%), Gross Margin (64.3% vs 78.8%).